National Institutes of Health

9000 Rockville Pike
Bethesda, MD - 20892

National Institutes of Health News

House oversight subcommittee reports on safety of bioresearch labs

Thursday, Apr 21, 2016 @ 1:36pm by BioPrepWatch Reports

The House Energy and Commerce Subcommittee on Oversight and Investigations has released a report on its investigation of allegations that a bioresearch lab in Maryland mishandled vials of smallpox.
Read More »

Immunovaccine joins hunt for Zika vaccine

Saturday, Mar 5, 2016 @ 9:27am by BioPrepWatch Reports

The immunotherapy company Immunovaccine Inc. announced Thursday that it will puts its resources behind the global effort to develop an effective vaccine for the Zika virus.
Read More »

University of Texas renames Center for Infectious Disease after late scientist

Saturday, Jan 16, 2016 @ 9:20am by BioPrepWatch Reports

Dr. John LaMontagne will have a research center named after him at the University of Texas.
Read More »

Malaria treatments ineffective against drug-resistant parasites in Cambodia

Monday, Jan 11, 2016 @ 4:26pm by BioPrepWatch Reports

Researchers from the NIAID, a branch of the NIH, found that the first-line malaria treatment being used in Cambodia is ineffective because the parasites have developed resistance.
Read More »

Registration opens for PHEMCE 2016 Stakeholders Workshop

Thursday, Dec 3, 2015 @ 2:26pm by BioPrepWatch Reports

The Public Health Emergency Medical Countermeasures Enterprise has announced that registration for its Stakeholders Workshop closes Friday, Dec. 11.
Read More »

NIH initiates chikungunya vaccine trial

Saturday, Nov 28, 2015 @ 12:25pm by BioPrepWatch Reports

NIH opened a clinical trial for a vaccine candidate against the chikungunya virus this week.
Read More »

NIH study indicates Ebola's ability to persist in semen

Sunday, Nov 22, 2015 @ 4:58pm by BioPrepWatch Reports

The Centers for Disease Control and Prevention’s (CDC) Emerging Infectious Diseases released a recent study that indicates that the Ebola virus persists after infection in certain bodily fluids.
Read More »

NIH issues sources sought notice on capabilities of small, struggling businesses

Wednesday, Nov 18, 2015 @ 4:24pm by BioPrepWatch Reports

The National Institutes of Health (NIH) recently issued a sources sought notice on the capabilities of small and disadvantaged businesses that would be interested in working in research and production related to clinical materials.
Read More »

Profectus BioSciences presents pre-clinical filovirus vaccine data

Wednesday, Nov 18, 2015 @ 10:16am by BioPrepWatch Reports

Profectus BioSciences recently presented pre-clinical data on its VesiculoVax vaccine candidate.
Read More »

NIH issues 'sources sought' notification for pathogen research

Wednesday, Nov 18, 2015 @ 9:50am by BioPrepWatch Reports

The National Institutes of Health (NIH) issued a "sources sought" notification in researching host and pathogen interactions this week.
Read More »

NIH releases information on organophosphate research

Tuesday, Oct 27, 2015 @ 12:15pm by BioPrepWatch Reports

The National Institutes of Health (NIH) has released information on a project through the University of Montana that they have provided funding for, in which researchers study the properties of organophosphates found in nerve agents.
Read More »

NIH, NIAID issue sources sought notice

Thursday, Oct 22, 2015 @ 10:52am by BioPrepWatch Reports

The National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID) issued a sources sought notice for small businesses earlier this month.
Read More »

NIH issues National Biosafety Stewardship Month notice

Wednesday, Oct 21, 2015 @ 4:40pm by BioPrepWatch Reports

The National Institutes of Health (NIH) issued a notice at the end of September that announced the National Biosafety Stewardship Month and served as a reminder of health and safety requirements for grantees.
Read More »

Favipiravir shows positive results as Lassa virus treatment in animal models

Friday, Oct 16, 2015 @ 7:21pm by BioPrepWatch Reports

A study from the National Institutes of Health indicated that a candidate treatment for the Ebola virus has shown efficacy against the Lassa virus in animal models, it announced on Tuesday.
Read More »

DTRA offers contract to foster laboratory capability in Cambodia and Thailand

Thursday, Oct 8, 2015 @ 3:05pm by BioPrepWatch Reports

The Defense Threat Reduction Agency (DTRA) is seeking to execute a sole source contract in order to increase the laboratory capabilities of Thailand and Cambodia to be able to better detect pathogens, they announced on Sept. 28.
Read More »

NIH issues details for CNS program

Wednesday, Sep 30, 2015 @ 7:47am by BioPrepWatch Reports

The National Institutes of Health (NIH) released details this month on a new program, called the CounterACT Neurotherapeutics Screening (CNS) Program, in order to accelerate countermeasure development for chemical threats.
Read More »

Bavarian Nordic awarded $9 million Janssen contract

Tuesday, Sep 15, 2015 @ 9:20am by BioPrepWatch Reports

BARDA funds will be used to further develop possible Ebola vaccine boost regimen
Read More »

ASM announces $20 million diagnostic competition

Saturday, Sep 12, 2015 @ 11:17am by BioPrepWatch Reports

The Chair of the American Society for Microbiology's (ASM) Public and Scientific Affair Board Ronald Atlas announced Friday that there will be a prize competition for diagnostics for antibiotic-resistant pathogens.
Read More »

TP-271 approved for expedited review process

Friday, Sep 4, 2015 @ 4:02pm by BioPrepWatch Reports

The U.S. Food and Drug Administration has granted a Qualified Infectious Disease Product (QIDP) and Fast Track designations to Tetraphase Pharmaceuticals Inc.'s TP-271 antibiotic candidate, the company announced Thursday.
Read More »

PositiveID’s handheld device makes rapid biological testing user-friendly

Monday, Jun 8, 2015 @ 5:25pm by BioPrepWatch Reports

PositiveID Corp. is developing a device that’s poised to revolutionize the growing sector within medical equipment known as molecular diagnostics and testing equipment, a multi-billion-dollar market focused on real-time or quantitative PCR (polymerase chain reaction) pathogen detection.
Read More »